VAERS Explorer
Back to explore

Report #2871138

Received Nov 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
CA
Recovered
Unknown
Vaccinated
Nov 3, 2025
Onset
Nov 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKJ9493—

Symptoms (1)

Expired product administered

Symptom narrative

Expired dose given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 61-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number J9493, expiry date 01-NOV-2025) for prophylaxis. On 03-NOV-2025, the patient received Arexvy. On 03-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date:03-NOV-2025 A pharmacist called in to request data about the administration of an expired dose of Arexvy. The Vaccine Administration Facility is the same as Primary Reporter.